Sources: 12Gene Ontology See all sources |
Cellular components related to polyposis according to GeneDecks:| id | Name | GO ID | Score | Top Affiliating Genes | | 1 | cytosol | GO:005829 | 16.0 | GUK1, AMD1, CASP7, CASP3, CAT, CA1 | | 2 | nucleus | GO:005634 | 15.6 | VDR, LMNA, MYC, RARB, RASSF1, USF2 | | 3 | cytoplasm | GO:005737 | 14.3 | XPO1, GSTP1, FGF2, MEN1, IL11, IL13 | | 4 | nucleoplasm | GO:005654 | 12.1 | CDKN1A, ESR2, TP53, DDIT3, PPARG, PPARA | | 5 | transcription factor complex | GO:005667 | 11.1 | CTBP1, CDK4, CDK2, JUN, ATF4, LEF1 | | 6 | protein complex | GO:043234 | 10.3 | ALB, HNF1A, TP53, PTGS2, TOP2A, SYP | | 7 | external side of plasma membrane | GO:009897 | 9.0 | IL1RL1, IL17A, IL13, ITGAE, CD274, CD40LG | | 8 | extracellular region | GO:005576 | 8.9 | ESR2, IL6, HSPG2, HLA-C, TUBA4A, TMEFF2 | | 9 | extracellular space | GO:005615 | 8.2 | CSF1, CSF2, WNT5A, HGF, SOD1, MMP9 | | 10 | plasma membrane | GO:005886 | INF | DLG3, DLG4, SRC, CTNNA1, CTNNB1, CTNND1 |
Biological processes related to polyposis according to GeneDecks: (show top 50)
(show all 76)
| id | Name | GO ID | Score | Top Affiliating Genes | | 1 | apoptotic process | GO:006915 | 12.8 | PDCD1, PCNT, BUB1, BUB1B, VIM, BRCA1 | | 2 | Wnt receptor signaling pathway | GO:016055 | 12.5 | BTRC, LEF1, CDC73, APC2, APCDD1, MCC | | 3 | canonical Wnt receptor signaling pathway | GO:060070 | 12.4 | SFRP1, MYC, LEF1, AXIN1, CDC42, GSK3B | | 4 | positive regulation of transcription, DNA-dependent | GO:045893 | 12.3 | KLF4, KLF6, RELA, SFRP1, BTRC, RB1 | | 5 | cell proliferation | GO:008283 | 12.3 | KITLG, KIF2C, PCNA, BUB1, BUB1B, KHDRBS1 | | 6 | protein phosphorylation | GO:006468 | 12.2 | BRAF, BMPR1A, BMPR1B, BIRC5, CDK4, IRF1 | | 7 | negative regulation of transcription from RNA polymerase II promoter | GO:000122 | 12.2 | KLF4, VHL, VDR, MYC, MYB, BMP2 | | 8 | negative regulation of canonical Wnt receptor signaling pathway | GO:090090 | 12.1 | SFRP1, LEF1, AXIN2, CDH2, GSK3B, APC | | 9 | transcription initiation from RNA polymerase II promoter | GO:006367 | 12.0 | SERPINE1, VDR, MYC, RARB, UBC, AR | | 10 | response to DNA damage stimulus | GO:006974 | 11.9 | BRCA1, MYC, RASSF1, BCL2, CHEK1, BAX | | 11 | mitotic cell cycle | GO:000278 | 11.7 | KIF2C, PCNA, PCNT, BUB1, BUB1B, BUB3 | | 12 | transforming growth factor beta receptor signaling pathway | GO:007179 | 11.7 | SERPINE1, MYC, BMPR1A, USP15, UBC, XPO1 | | 13 | DNA repair | GO:006281 | 11.6 | PCNA, BRCA1, BRCA2, CHEK1, MUTYH, UBC | | 14 | induction of apoptosis by intracellular signals | GO:008629 | 11.5 | MYC, CLU, BCL2, BAX, MSH6, CDKN1A | | 15 | positive regulation of apoptotic process | GO:043065 | 11.5 | SFRP1, BMP2, RARB, CLU, SCRIB, BAX | | 16 | negative regulation of transforming growth factor beta receptor signaling pathway | GO:030512 | 11.5 | PIN1, USP15, UBC, XPO1, ENG, TP53 | | 17 | cell cycle arrest | GO:007050 | 11.5 | RB1, MYC, RASSF1, KHDRBS1, MSH2, ATM | | 18 | negative regulation of cell growth | GO:030308 | 11.4 | SFRP1, RB1, BMPR2, BCL2, CDKN1A, CDKN1B | | 19 | positive regulation of pathway-restricted SMAD protein phosphorylation | GO:010862 | 11.4 | BMP2, BMP6, BMPR1A, BMPR2, INHBA, ENG | | 20 | negative regulation of cell proliferation | GO:008285 | 11.4 | KLF4, KIFAP3, SFRP1, VHL, VDR, BMP2 | | 21 | negative regulation of transcription, DNA-dependent | GO:045892 | 11.3 | KLF4, RELA, SFRP1, BTRC, RB1, BRCA1 | | 22 | epidermal growth factor receptor signaling pathway | GO:007173 | 11.2 | UBC, CDKN1B, CDC42, GSK3B, CASP9, HRAS | | 23 | positive regulation of bone mineralization | GO:030501 | 11.2 | BMP2, BMP6, BMPR1A, BMPR1B, BMPR2, FBN2 | | 24 | signal transduction | GO:007165 | 11.2 | PDCD1, KIFAP3, KITLG, BTRC, VDR, RARB | | 25 | response to drug | GO:042493 | 11.1 | SFRP1, MYC, BCL2, LGALS1, CHRNA3, UGT1A1 | | 26 | positive regulation of cell migration | GO:030335 | 11.0 | VEGFA, BMP2, LEF1, CDH13, MMP14, ILK | | 27 | response to organic cyclic compound | GO:014070 | 11.0 | SFRP1, LEF1, UGT1A1, MSH2, JUN, CDKN1A | | 28 | positive regulation of protein phosphorylation | GO:001934 | 11.0 | PIN1, VEGFA, BMP2, AXIN1, AXIN2, IL1B | | 29 | blood coagulation | GO:007596 | 11.0 | PIK3CG, SH2B3, KIFAP3, KIF3A, KIF2C, SERPINE1 | | 30 | response to gamma radiation | GO:010332 | 10.8 | BRCA2, MYC, BCL2, BAX, MEN1, IL1A | | 31 | positive regulation of osteoblast differentiation | GO:045669 | 10.6 | BMP2, BMP6, BMPR1A, BMPR1B, BMPR2, FGF2 | | 32 | induction of apoptosis | GO:006917 | 10.6 | BAX, CDKN1B, CDKN2A, IRF1, INHBA, CASP3 | | 33 | cellular response to organic cyclic compound | GO:071407 | 10.5 | BTRC, BMP2, LGALS1, CDKN1B, MGMT, IL1B | | 34 | positive regulation of endothelial cell proliferation | GO:001938 | 10.5 | VEGFA, BMP2, BMP6, BMPR2, JUN, CDH13 | | 35 | positive regulation of transcription from RNA polymerase II promoter | GO:045944 | 10.5 | KLF4, KLF6, RELA, RB1, SERPINE1, BRCA1 | | 36 | aging | GO:007568 | 10.5 | VDR, VCAM1, JUN, IL1B, CCL2, CCL5 | | 37 | positive regulation of sequence-specific DNA binding transcription factor activity | GO:051091 | 10.5 | JUP, IL10, IL1B, IL4, IL5, IL6 | | 38 | anti-apoptosis | GO:006916 | 10.4 | RELA, BRAF, VHL, BIRC5, BCL2, MUC1 | | 39 | positive regulation of fibroblast proliferation | GO:048146 | 10.4 | MYC, JUN, CDKN1A, CDK4, IGF1, PDGFB | | 40 | negative regulation of apoptotic process | GO:043066 | 10.3 | PIK3CG, RELA, SFRP1, SERPINE1, BRAF, VEGFA | | 41 | activation of cysteine-type endopeptidase activity involved in apoptotic process | GO:006919 | 10.2 | MYC, BAX, XDH, CDKN1B, CDKN2A, IFI27 | | 42 | cellular response to interleukin-1 | GO:071347 | 10.0 | RELA, SFRP1, MMP9, IRF1, IL17A, IL8 | | 43 | positive regulation of NF-kappaB transcription factor activity | GO:051092 | 10.0 | RELA, CLU, UBC, AR, IL1B, IL6 | | 44 | inflammatory response | GO:006954 | 9.9 | PIK3CG, RELA, SELE, BMP2, BMP6, BMPR1B | | 45 | response to hypoxia | GO:001666 | 9.8 | VEGFA, VCAM1, BMP2, USF1, BCL2, ATM | | 46 | platelet activation | GO:030168 | 9.7 | PIK3CG, SERPINE1, VEGFA, RAC1, CLU, CD40LG | | 47 | immune response | GO:006955 | 9.5 | BMP6, BMPR1A, CD274, IL13, IL17A, IL1A | | 48 | cytokine-mediated signaling pathway | GO:019221 | 9.4 | PIN1, KLF6, RELA, VCAM1, LIFR, UBC | | 49 | positive regulation of nitric oxide biosynthetic process | GO:045429 | 9.2 | IL1B, IFNG, ICAM1, ESR1, TNF, PTGS2 | | 50 | positive regulation of cell proliferation | GO:008284 | INF | SFRP1, VIP, VEGFA, MYC, LIFR, BIRC5 |
Molecular functions related to polyposis according to GeneDecks: (show all 16)
| id | Name | GO ID | Score | Top Affiliating Genes | | 1 | enzyme binding | GO:019899 | 13.0 | PPARG, NR5A1, NOD2, RXRA, EGFR, H2AFX | | 2 | protein kinase binding | GO:019901 | 12.5 | SMAD3, USF1, MAP3K1, APC, ILK, GSK3B | | 3 | beta-catenin binding | GO:008013 | 12.2 | CSNK2A1, CTNNBIP1, TCF7L2, SMAD3, BTRC, LEF1 | | 4 | protein homodimerization activity | GO:042803 | 12.0 | BMPR1A, USF2, USF1, BIRC5, CLIP1, BCL2 | | 5 | sequence-specific DNA binding transcription factor activity | GO:003700 | 12.0 | ESR2, PPARA, TP53, TBX21, DDIT3, CTBP1 | | 6 | protein heterodimerization activity | GO:046982 | 11.8 | HGF, HNF1A, TCF4, UGT1A6, BAX, INHBA | | 7 | transcription factor binding | GO:008134 | 11.6 | CDKN2A, AR, TP53, TNFRSF10A, DDIT3, CTBP1 | | 8 | transcription regulatory region DNA binding | GO:044212 | 11.4 | AR, LEF1, BRCA1, RELA, KLF4, JUN | | 9 | double-stranded DNA binding | GO:003690 | 11.2 | NFKB1, EGFR, STAT1, RXRA, SMAD3, SMAD2 | | 10 | identical protein binding | GO:042802 | 11.1 | IGF1R, GLUL, ESR1, TP53, CSNK2B, STK4 | | 11 | steroid hormone receptor activity | GO:003707 | 11.0 | PPARD, HNF4A, NR5A1, VDR, RARB, RXRA | | 12 | chromatin binding | GO:003682 | 10.8 | TGIF1, TFAP2A, TOP2A, PRKCB, RELA, GATA2 | | 13 | ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity | GO:004879 | 10.8 | AR, HNF4A, ESR2, PTGER3, PPARD, NR1H2 | | 14 | growth factor activity | GO:008083 | 9.4 | IL5, CSF2, VEGFA, BMP2, BMP6, INHBA | | 15 | cytokine activity | GO:005125 | 9.1 | IL2, IL1B, IL1A, IL17A, IL13, IL11 | | 16 | protein binding | GO:005515 | INF | RXRA, ACVRL1, ELAVL1, H2AFX, HIF1A, TOP2A |
|